Pharmacy Times

SEPTEMBER 25, 2023

Physical symptoms of burnout can include headaches, digestive problems, sleep disturbances, and increased susceptibility to illnesses due to a weakened immune system.

Immunization 167

Immunization 167

Drug Topics

SEPTEMBER 26, 2023

Pharmacists at nearly 2 dozen CVS pharmacy locations called out sick Thursday and Friday to protest recent corporate decisions they say put patients at risk of serious harm.

247

247

Pharmacy Times

SEPTEMBER 27, 2023

Working together, pharmacies and labs can answer the call to align and back legislation that supports pharmacists as providers, help patients gain greater access to affordable care, and reap the benefits of improved health outcomes while growing business revenue.

Patient Care 156

Patient Care 156

STAT

SEPTEMBER 29, 2023

The World Health Organization has recommended dropping a component of many flu vaccines because the viruses it protects against appear to have been driven into extinction in the Covid-19 pandemic. A family of viruses known as influenza B/Yamagata has not been seen since March 2020, when flu circulation worldwide declined to very low levels in the face of the onslaught of Covid and the protections people took to avoid contracting it.

Vaccines 145

Vaccines 145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Fierce Healthcare

SEPTEMBER 21, 2023

Federal regulators have accused a major Texas-based anesthesia provider and its parent private equity firm of a decade-long, three-pronged scheme to suppress competition and drive-up prices. | U.S. Anesthesia Partners and Welsh, Carson, Anderson & Stowe, its private equity backer, have "cost Texans tens of millions of dollars more each year" by suppressing competition over the course of a decade, the regulator alleges.

145

145

Fierce Pharma

SEPTEMBER 11, 2023

Out with the old and in with the new: Monday, the U.S. | The FDA has approved Pfizer and Moderna’s separate vaccine formulations that target current variants of the disease. Each company’s shot is approved for people ages 12 and up and emergency authorized for patients 6 months old to 11 years old.

Vaccines 145

Vaccines FDA 145

Drug Topics

SEPTEMBER 29, 2023

When rural areas lose hospitals and primary care clinics, residents must turn to pharmacies to receive the care they need.

Hospitals 261

Hospitals 261

Pharmacy Times

SEPTEMBER 19, 2023

Moving cannabis to Schedule 3 will make it easier to research, resulting in the development and creation of new cannabinoid-based pharmaceuticals, with notable potential in oncology.

164

164

STAT

SEPTEMBER 28, 2023

WASHINGTON — After Pfizer and Moderna hiked the prices of their Covid-19 vaccines this year, the federal government will now pay nearly three times more than it did previously for each dose. And it’s paying more than countries that did far less to support vaccine development. Health and Human Services Secretary Xavier Becerra glossed over the dramatic increase in the amount the government is paying for vaccines in a public appearance last week, when he got vaccinated at a CVS pharm

Vaccines 145

Vaccines 145

Fierce Healthcare

SEPTEMBER 19, 2023

Software giant Oracle has integrated generative AI services into its Cerner electronic medical record system as health IT companies race to harness this cutting-edge tech for providers. | Software giant Oracle has integrated generative AI services into its Cerner EHR system as health tech companies race to harness this cutting-edge tech for providers.

Cerner 143

Cerner Medical Records 143

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

SEPTEMBER 7, 2023

Demand is so strong for Novo Nordisk’s obesity drugs that the only limitation on sales—in the short term—seems to be the company’s ability to produce them. | Promising heart data for Novo Nordisk's Wegovy are a "paradigm shift," according to J.P. Morgan, which has doubled its market projection for GLP-1 diabetes and obesity treatments to $71 billion for 2032.

139

139

Hospital Pharmacy Europe

SEPTEMBER 25, 2023

The benefits of ensitrelvir use in patients with symptoms of long Covid and as a second-line treatment option for those hospitalised with Covid-19, have been presented at the recent European Scientific Working Group on Influenza and other Acute Respiratory Viruses’ (ESWI) Influenza Conference. Ensitrelvir is an oral antiviral drug for Covid-19 manufactured by Shionogi, which is currently approved under the emergency regulatory approval system in Japan.

Hospitals 126

Hospitals FDA 126

Drug Topics

SEPTEMBER 18, 2023

From automated medication dispensing systems to telepharmacy services, technology can help reduce the risk of adverse patient events.

Medication Dispensing 247

Medication Dispensing 247

Pharmacy Times

SEPTEMBER 8, 2023

Although findings indicate a relationship between vitamin D and mood disorders, further research is needed to clarify efficacy of specific vitamin D levels, as well as supplement dose and form.

162

162

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

SEPTEMBER 28, 2023

New data released Thursday by the National Science Foundation show the exodus of young life scientists from the Ivory Tower to industry has reached the highest level in nearly three decades, deepening concerns about the future of academic science in the U.S. Among newly minted life science Ph.D.s in 2022 who had firm next steps, roughly 53% planned to pursue postdoctoral research, a temporary period of additional training that is virtually a requirement for those hoping to land a faculty job.

145

145

Fierce Healthcare

SEPTEMBER 27, 2023

Amazon announced this week that it would invest up to $4 billion in artificial intelligence company Anthropic as the AI arms race heats up. | Amazon announced this week that it would invest up to $4 billion in artificial intelligence company Anthropic as the AI arms race heats up. The collaboration introduces more competition and more options for healthcare teams looking to innovate using different approaches or to get more tactical with their AI strategy, one health IT expert said.

142

142

Fierce Pharma

SEPTEMBER 22, 2023

Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break. | Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break. Following a series of trial shortfalls this year in melanoma, colorectal cancer and head and neck squamous cell carcinoma, the duo has missed the mark in yet another set of clinical trials—this time in non-small cell lung cancer.

138

138

European Pharmaceutical Review

SEPTEMBER 12, 2023

As part of The Future of Pharma/Biopharma Analysis 2023 , which took place on 28-29 June 2023, European Pharmaceutical Review ( EPR ) gathered an expert panel to discuss developing a modern contamination control strategy. The participants were: Dr Tim Sandle, Head of GxP Compliance at Bio Products Laboratory Limited (BPL) as moderator; Dr Edward Tidswell, Executive Director within the Microbiological Quality and Sterility Assurance organisation of Merck & Co; Frederic Ayers, Research Scienti

Documentation 127

Documentation 127

Drug Topics

SEPTEMBER 27, 2023

The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.

252

252

Pharmacy Times

SEPTEMBER 22, 2023

Empagliflozin (Jardiance) demonstrated a 28% relative risk reduction, with an absolute risk reduction of 3.6% per patient-year at risk in the treatment of chronic kidney disease.

FDA 156

FDA 156

STAT

SEPTEMBER 27, 2023

On a mild May day in 1993, about 60 scientists and doctors gathered on a lawn in Copenhagen to commemorate the first International Symposium on GLP-1, the hormone that decades later would become the basis for highly effective diabetes and obesity drugs like Ozempic and Wegovy. The meeting was a scientific showcase of all the leading experts in the nascent field.

Hospitals 145

Hospitals 145

Fierce Healthcare

SEPTEMBER 25, 2023

Healthcare organizations are continuing to push the Centers for Medicare & Medicaid Services (CMS) to rethink its coverage policy for anti-obesity medications. | Critics say that the view CMS has of certain anti-obesity medications is outdated and could be covered under Medicare Part D.

137

137

Fierce Pharma

SEPTEMBER 25, 2023

More than five years after an initial FDA approval, Novartis is touting positive trial results for its radiotherapy Lutathera as a first-line therapy against the rare cancer that killed Apple co-fo | More than five years after an initial FDA approval, Novartis is touting positive trial results for its radiotherapy Lutathera as a first-line therapy against the rare cancer that killed Apple co-founder Steve Jobs.

FDA 135

FDA 135

PharmaVoice

SEPTEMBER 19, 2023

This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.

145

145

Pharmaceutical Technology

SEPTEMBER 28, 2023

The company’s algorithms put proteins through millions of years of simulated evolution to identify potential functional candidates.

126

126

Pharmacy Times

SEPTEMBER 26, 2023

Tune in to this episode of the Independent Rx Forum to gain a comprehensive understanding of the enduring significance of independent and community pharmacies.

Community Pharmacies 160

Community Pharmacies 160

STAT

SEPTEMBER 27, 2023

Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation. Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

145

145

Fierce Healthcare

SEPTEMBER 12, 2023

As at-home healthcare becomes more tech-driven—think wireless biosensors and connected blood pressure cuffs—it creates more logistical challenges for providers. | Geisinger's pilot program with Best Buy's Geek Squad resulted in quicker access to care, better adherence to care plans and more positive outcomes for chronic care patients, the organizations said.

138

138

Fierce Pharma

SEPTEMBER 28, 2023

Fabre-Kramer Pharmaceuticals' major depressive disorder (MDD) drug gepirone has been rejected by the FDA not once, not twice, but three times since the turn of the millennium. | Fabre-Kramer's Exxua suffered three prior FDA rejections before scoring an FDA approval for major depressive disorder last week. Its label doesn't include sexual dysfunction as an adverse reaction, which is rare among antidepressants.

Adverse Reactions 134

Adverse Reactions FDA Labelling 134

pharmaphorum

SEPTEMBER 15, 2023

FTC fires shot across pharma's bows over 'improper' patents Phil.

140

140

Pharmaceutical Technology

SEPTEMBER 20, 2023

The neurotech will receive the investment in Series B equity financing round to invest in Alzheimer’s disease research.

129

129

Pharmacy Times

SEPTEMBER 12, 2023

One IVIG product showed overall improvement in neuroprotection, including alleviating cognitive decline and ameliorating AB deposition in Alzheimer disease.

160

160

STAT

SEPTEMBER 30, 2023

Next week, 50 medical experts from the Karolinska Institutet in Stockholm will meet to award the 2023 Nobel Prize for Physiology or Medicine. The vote takes place on Oct. 2, but betting-minded scientists are already beginning to make their picks for who might take home the gold. Seasoned Nobel prognosticators will point out that the medicine prize often cycles between super-basic molecular biology and inventions that actually cure people.

145

145

Fierce Healthcare

SEPTEMBER 25, 2023

Costco is joining retail competitors Walgreens, Walmart and CVS Health by expanding its healthcare footprint. | The big-box retailer teamed up with startup Sesame to offer special discount pricing to Costco members on a broad range of outpatient medical care services, including telehealth visits.

136

136